Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 8,899Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1MSN LABORATORIES PRIVATE LIMITED Kardanur Village IN

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

Looking for 755037-03-7 / Regorafenib API manufacturers, exporters & distributors?

Regorafenib manufacturers, exporters & distributors 1

36

PharmaCompass offers a list of Regorafenib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Regorafenib manufacturer or Regorafenib supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Regorafenib manufacturer or Regorafenib supplier.

PharmaCompass also assists you with knowing the Regorafenib API Price utilized in the formulation of products. Regorafenib API Price is not always fixed or binding as the Regorafenib Price is obtained through a variety of data sources. The Regorafenib Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Regorafenib

Synonyms

755037-03-7, Bay 73-4506, Stivarga, 4-(4-(3-(4-chloro-3-(trifluoromethyl)phenyl)ureido)-3-fluorophenoxy)-n-methylpicolinamide, Regorafenibum, Regorafenib (bay 73-4506)

Cas Number

755037-03-7

Unique Ingredient Identifier (UNII)

24T2A1DOYB

About Regorafenib

Regorafenib is the anhydrous form of regorafenib, an orally bioavailable small molecule with potential antiangiogenic and antineoplastic activities. Regorafenib binds to and inhibits vascular endothelial growth factor receptors (VEGFRs) 2 and 3, and Ret, Kit, PDGFR and Raf kinases, which may result in the inhibition of tumor angiogenesis and tumor cell proliferation. VEGFRs are receptor tyrosine kinases that play important roles in tumor angiogenesis; the receptor tyrosine kinases RET, KIT, and PDGFR, and the serine/threonine-specific Raf kinase are involved in tumor cell signaling.

Regorafenib Monohydrate Manufacturers

A Regorafenib Monohydrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Regorafenib Monohydrate, including repackagers and relabelers. The FDA regulates Regorafenib Monohydrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Regorafenib Monohydrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Regorafenib Monohydrate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Regorafenib Monohydrate Suppliers

A Regorafenib Monohydrate supplier is an individual or a company that provides Regorafenib Monohydrate active pharmaceutical ingredient (API) or Regorafenib Monohydrate finished formulations upon request. The Regorafenib Monohydrate suppliers may include Regorafenib Monohydrate API manufacturers, exporters, distributors and traders.

click here to find a list of Regorafenib Monohydrate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Regorafenib Monohydrate CEP

A Regorafenib Monohydrate CEP of the European Pharmacopoeia monograph is often referred to as a Regorafenib Monohydrate Certificate of Suitability (COS). The purpose of a Regorafenib Monohydrate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Regorafenib Monohydrate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Regorafenib Monohydrate to their clients by showing that a Regorafenib Monohydrate CEP has been issued for it. The manufacturer submits a Regorafenib Monohydrate CEP (COS) as part of the market authorization procedure, and it takes on the role of a Regorafenib Monohydrate CEP holder for the record. Additionally, the data presented in the Regorafenib Monohydrate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Regorafenib Monohydrate DMF.

A Regorafenib Monohydrate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Regorafenib Monohydrate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.

click here to find a list of Regorafenib Monohydrate suppliers with CEP (COS) on PharmaCompass.

Regorafenib Monohydrate Manufacturers | Traders | Suppliers

Regorafenib Monohydrate Manufacturers, Traders, Suppliers 1
31

We have 1 companies offering Regorafenib Monohydrate

Get in contact with the supplier of your choice:

  1. MSN Laboratories
Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.